Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05847530 · ClinicalTrials.gov registry record · NA
Pilot Evaluation of the Cynosure Potenza™ System for Treatment of Cosmetic Dermatologic Skin Conditions
A NA study, sponsored by Cynosure.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT05847530 is a NA study that has completed, run by Cynosure. The registered enrollment target is 20 participants.
The verdict
NCT05847530, a NA study, has completed, sponsored by Cynosure.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
The primary objective of this pilot study is exploratory investigation evaluating the Potenza microneedle fractional radiofrequency (RF) device and may be used in combination with the Icon intense pulsed light (IPL) device.
Interventions
- DEVICE Potenza
- DEVICE Icon
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2023-08-17 |
| Est. Completion | 2025-05-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05847530
The ClinicalTrials.gov registry entry for NCT05847530 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cynosure, which has 49 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Potenza is the first listed.
NCT05847530 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05847530 about?
NCT05847530 is a clinical study titled "Pilot Evaluation of the Cynosure Potenza™ System for Treatment of Cosmetic Dermatologic Skin Conditions". The primary objective of this pilot study is exploratory investigation evaluating the Potenza microneedle fractional radiofrequency (RF) device and may be used in combination with the Icon intense pulsed light (IPL) device.
What is the current status of trial NCT05847530?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2023-08-17. Estimated completion is 2025-05-06.
What interventions are being tested in trial NCT05847530?
The interventions under investigation include: Potenza (DEVICE), Icon (DEVICE).
Who is sponsoring clinical trial NCT05847530?
This trial is sponsored by Cynosure, which has 49 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.